Description
Yangling JITAI Pharmaceutical Co., Ltd is a comprehensive provider within the pharmaceutical sector, specialising in Contract Manufacturing (CMO/CDMO), Contract Research Organisation (CRO) activities, and distribution of pharmaceutical products. Established in 2002 with a start-up capital of RMB60 million, the company has developed into a modern GMP manufacturer, focusing on the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and food production. The company also boasts a dedicated R&D lab centre, primarily undertaking DMO services for APIs and Finished Pharmaceutical Products (FPP), facilitating both pilot testing and large-scale production for new drugs.
Services include:
– APIs (Active Pharmaceutical Ingredients)
– Pharmaceuticals production
– Intermediates manufacturing
– Food production
– Research and Development (R&D) services
– Pilot test and production services for new drugs
Yangling JITAI Pharmaceutical Co., Ltd stands as a reliable partner in the pharmaceutical industry, committed to quality and innovation. For more information, please visit .
Capabilities
Contact Information
Related Listings

CDMO Live Europe 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st May 2026

External Manufacturing Leaders Boston 2026
Exclusive event for senior external manufacturing leaders. Boston, January 2026











